![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » Sinobiopharma Reports 350 Percent Increase in Production of Flagship Drug
Sinobiopharma Reports 350 Percent Increase in Production of Flagship Drug
May 15, 2009
Sinobiopharma, Inc. is pleased to announce that production of its flagship drug, Cisatracurium Besylate, increased by 350% in the first quarter of 2009 compared to production in the first quarter of 2008.
TradingMarkets
TradingMarkets
Upcoming Events
-
21Oct